Treace Medical Concepts, Inc. TMCI Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Treace Medical Concepts, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s financing cash flow?
- Treace Medical Concepts, Inc. (TMCI) reported financing cash flow of -$588K in Q1 2026.
- How has Treace Medical Concepts, Inc.'s financing cash flow changed year-over-year?
- Treace Medical Concepts, Inc.'s financing cash flow decreased by 108.5% year-over-year, from -$282K to -$588K.
- What is the long-term trend for Treace Medical Concepts, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s financing cash flow has grown at a -62.7% compound annual growth rate (CAGR), from $107.65M to $2.09M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.